OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers
Watsamon Jantarabenjakul, Pimpayao Sodsai, Napaporn Chantasrisawad, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 639-639
Open Access | Times Cited: 21
Watsamon Jantarabenjakul, Pimpayao Sodsai, Napaporn Chantasrisawad, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 639-639
Open Access | Times Cited: 21
Showing 21 citing articles:
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
Jeffrey P. Townsend, Hayley B. Hassler, Pratha Sah, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 69
Jeffrey P. Townsend, Hayley B. Hassler, Pratha Sah, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 69
Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination
Maaweya Awadalla, Halah Z. AlRawi, Rahaf A. Henawi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Maaweya Awadalla, Halah Z. AlRawi, Rahaf A. Henawi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its Predictors
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1097-1097
Open Access | Times Cited: 45
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1097-1097
Open Access | Times Cited: 45
Predictors of second COVID ‐19 booster dose or new COVID ‐19 vaccine hesitancy among nurses: A cross‐sectional study
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
Journal of Clinical Nursing (2022) Vol. 32, Iss. 13-14, pp. 3943-3953
Open Access | Times Cited: 24
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
Journal of Clinical Nursing (2022) Vol. 32, Iss. 13-14, pp. 3943-3953
Open Access | Times Cited: 24
Hesitancy to Receive the Second COVID-19 Vaccine Booster Dose among Older Adults in Hong Kong: A Random Telephone Survey
Paul Chan, Marco Lok-tin Lee, Yuan Fang, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 392-392
Open Access | Times Cited: 12
Paul Chan, Marco Lok-tin Lee, Yuan Fang, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 392-392
Open Access | Times Cited: 12
Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital
Vidya Arankalle, A. G. Kulkarni, Ruta Kulkarni, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Vidya Arankalle, A. G. Kulkarni, Ruta Kulkarni, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Moe H. Kyaw, Júlia Spinardi, Ling Zhang, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort
René Clavero, Alfredo Parra-Lucares, Gabriel Méndez-Valdés, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1542-1542
Open Access | Times Cited: 12
René Clavero, Alfredo Parra-Lucares, Gabriel Méndez-Valdés, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1542-1542
Open Access | Times Cited: 12
One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test
Yeşim Tok, Rabia Can Sarınoğlu, Seyhan Ördekçi, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 355-355
Open Access | Times Cited: 6
Yeşim Tok, Rabia Can Sarınoğlu, Seyhan Ördekçi, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 355-355
Open Access | Times Cited: 6
Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: a cross-sectional study
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 9
T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1494-1494
Open Access | Times Cited: 9
Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1494-1494
Open Access | Times Cited: 9
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
Uraporn Phumisantiphong, Sirichan Chunhakan, Anan Manomaipiboon, et al.
Vaccine X (2023) Vol. 13, pp. 100277-100277
Open Access | Times Cited: 4
Uraporn Phumisantiphong, Sirichan Chunhakan, Anan Manomaipiboon, et al.
Vaccine X (2023) Vol. 13, pp. 100277-100277
Open Access | Times Cited: 4
Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents
Thanyawee Puthanakit, Rapisa Nantanee, Peera Jaru-Ampornpan, et al.
Vaccine X (2022) Vol. 12, pp. 100211-100211
Open Access | Times Cited: 7
Thanyawee Puthanakit, Rapisa Nantanee, Peera Jaru-Ampornpan, et al.
Vaccine X (2022) Vol. 12, pp. 100211-100211
Open Access | Times Cited: 7
Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster
Napaporn Chantasrisawad, Thanyawee Puthanakit, Katesiree Kornsitthikul, et al.
Vaccine X (2022) Vol. 12, pp. 100221-100221
Open Access | Times Cited: 6
Napaporn Chantasrisawad, Thanyawee Puthanakit, Katesiree Kornsitthikul, et al.
Vaccine X (2022) Vol. 12, pp. 100221-100221
Open Access | Times Cited: 6
Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination
Varalee Terbsiri, Opass Putcharoen, Gompol Suwanpimolkul, et al.
Vaccine X (2023) Vol. 14, pp. 100334-100334
Open Access | Times Cited: 3
Varalee Terbsiri, Opass Putcharoen, Gompol Suwanpimolkul, et al.
Vaccine X (2023) Vol. 14, pp. 100334-100334
Open Access | Times Cited: 3
Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
Supachaya Sriphoosanaphan, Sirinporn Suksawatamnuay, Nunthiya Srisoonthorn, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2126-2126
Open Access | Times Cited: 4
Supachaya Sriphoosanaphan, Sirinporn Suksawatamnuay, Nunthiya Srisoonthorn, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2126-2126
Open Access | Times Cited: 4
Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Monobiotinylated Proteins Tethered to Microspheres for Detection of Antigen-Specific Serum Antibodies
Caleb S. Whitley, Thomas C. Mitchell
Journal of Biological Methods (2022) Vol. 8, Iss. 4, pp. 1-1
Open Access | Times Cited: 1
Caleb S. Whitley, Thomas C. Mitchell
Journal of Biological Methods (2022) Vol. 8, Iss. 4, pp. 1-1
Open Access | Times Cited: 1
Antibody titers of individuals vaccinated for COVID-19: A systematic review
Aminoddin M Domado, Homobono Jacob F Adaza, Andrea Pauline Nicole C Beltran, et al.
Journal of Biosciences (2023) Vol. 48, Iss. 3
Closed Access
Aminoddin M Domado, Homobono Jacob F Adaza, Andrea Pauline Nicole C Beltran, et al.
Journal of Biosciences (2023) Vol. 48, Iss. 3
Closed Access
